List of Tables
Table 1. Global Point-of-care Testing (POCT) for Chronic Disease Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Point-of-care Testing (POCT) for Chronic Disease Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Point-of-care Testing (POCT) for Chronic Disease Market Competitive Situation by Manufacturers in 2024
Table 4. Global Point-of-care Testing (POCT) for Chronic Disease Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Chronic Disease Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Point-of-care Testing (POCT) for Chronic Disease Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Point-of-care Testing (POCT) for Chronic Disease, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Point-of-care Testing (POCT) for Chronic Disease, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Point-of-care Testing (POCT) for Chronic Disease, Product Type & Application
Table 12. Global Key Manufacturers of Point-of-care Testing (POCT) for Chronic Disease, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-of-care Testing (POCT) for Chronic Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Chronic Disease as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2020-2025) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region (2020-2025)
Table 19. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2026-2031) & (K Units)
Table 20. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region (2026-2031)
Table 21. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Region (2020-2025)
Table 23. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Region (2026-2031)
Table 25. North America Point-of-care Testing (POCT) for Chronic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2020-2025) & (K Units)
Table 27. North America Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2026-2031) & (K Units)
Table 28. North America Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2020-2025) & (K Units)
Table 32. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2026-2031) & (K Units)
Table 33. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Point-of-care Testing (POCT) for Chronic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Point-of-care Testing (POCT) for Chronic Disease Sales (K Units) by Type (2020-2025)
Table 51. Global Point-of-care Testing (POCT) for Chronic Disease Sales (K Units) by Type (2026-2031)
Table 52. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2020-2025)
Table 53. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2026-2031)
Table 54. Global Point-of-care Testing (POCT) for Chronic Disease Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Chronic Disease Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Type (2020-2025)
Table 57. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Type (2026-2031)
Table 58. Global Point-of-care Testing (POCT) for Chronic Disease Price (US$/Unit) by Type (2020-2025)
Table 59. Global Point-of-care Testing (POCT) for Chronic Disease Price (US$/Unit) by Type (2026-2031)
Table 60. Global Point-of-care Testing (POCT) for Chronic Disease Sales (K Units) by Application (2020-2025)
Table 61. Global Point-of-care Testing (POCT) for Chronic Disease Sales (K Units) by Application (2026-2031)
Table 62. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2020-2025)
Table 63. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2026-2031)
Table 64. Global Point-of-care Testing (POCT) for Chronic Disease Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Point-of-care Testing (POCT) for Chronic Disease Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Application (2020-2025)
Table 67. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Application (2026-2031)
Table 68. Global Point-of-care Testing (POCT) for Chronic Disease Price (US$/Unit) by Application (2020-2025)
Table 69. Global Point-of-care Testing (POCT) for Chronic Disease Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Point-of-care Testing (POCT) for Chronic Disease Product
Table 74. Abbott Recent Developments/Updates
Table 75. BioMerieux Company Information
Table 76. BioMerieux Description and Business Overview
Table 77. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product
Table 79. BioMerieux Recent Developments/Updates
Table 80. Siemens Healthineers Company Information
Table 81. Siemens Healthineers Description and Business Overview
Table 82. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product
Table 84. Siemens Healthineers Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Roche Point-of-care Testing (POCT) for Chronic Disease Product
Table 89. Roche Recent Developments/Updates
Table 90. Danaher Company Information
Table 91. Danaher Description and Business Overview
Table 92. Danaher Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Danaher Point-of-care Testing (POCT) for Chronic Disease Product
Table 94. Danaher Recent Developments/Updates
Table 95. Sinocare Inc Company Information
Table 96. Sinocare Inc Description and Business Overview
Table 97. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product
Table 99. Sinocare Inc Recent Developments/Updates
Table 100. Assure Tech (Hangzhou) Co.,Ltd. Company Information
Table 101. Assure Tech (Hangzhou) Co.,Ltd. Description and Business Overview
Table 102. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product
Table 104. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 105. Bio-Rad Laboratories Company Information
Table 106. Bio-Rad Laboratories Description and Business Overview
Table 107. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product
Table 109. Bio-Rad Laboratories Recent Developments/Updates
Table 110. Guangzhou Wondfo Biotech Co.,Ltd. Company Information
Table 111. Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
Table 112. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product
Table 114. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 115. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
Table 116. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Description and Business Overview
Table 117. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product
Table 119. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Point-of-care Testing (POCT) for Chronic Disease Distributors List
Table 123. Point-of-care Testing (POCT) for Chronic Disease Customers List
Table 124. Point-of-care Testing (POCT) for Chronic Disease Market Trends
Table 125. Point-of-care Testing (POCT) for Chronic Disease Market Drivers
Table 126. Point-of-care Testing (POCT) for Chronic Disease Market Challenges
Table 127. Point-of-care Testing (POCT) for Chronic Disease Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Point-of-care Testing (POCT) for Chronic Disease
Figure 2. Global Point-of-care Testing (POCT) for Chronic Disease Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Testing (POCT) for Chronic Disease Market Share by Type: 2024 & 2031
Figure 4. Based on Immunochromatography Product Picture
Figure 5. Based on Chemiluminescence Technology Product Picture
Figure 6. Based on Biosensor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Point-of-care Testing (POCT) for Chronic Disease Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Point-of-care Testing (POCT) for Chronic Disease Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. lndependent Testing Organization
Figure 12. Global Point-of-care Testing (POCT) for Chronic Disease Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Point-of-care Testing (POCT) for Chronic Disease Market Size (2020-2031) & (US$ Million)
Figure 14. Global Point-of-care Testing (POCT) for Chronic Disease Sales (2020-2031) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Chronic Disease Average Price (US$/Unit) & (2020-2031)
Figure 16. Point-of-care Testing (POCT) for Chronic Disease Report Years Considered
Figure 17. Point-of-care Testing (POCT) for Chronic Disease Sales Share by Manufacturers in 2024
Figure 18. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Point-of-care Testing (POCT) for Chronic Disease Players: Market Share by Revenue in Point-of-care Testing (POCT) for Chronic Disease in 2024
Figure 20. Point-of-care Testing (POCT) for Chronic Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2020-2031)
Figure 23. North America Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2020-2031)
Figure 24. United States Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2020-2031)
Figure 27. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2020-2031)
Figure 28. Germany Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Region (2020-2031)
Figure 35. China Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2020-2031)
Figure 43. Latin America Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Point-of-care Testing (POCT) for Chronic Disease by Type (2020-2031)
Figure 53. Global Revenue Market Share of Point-of-care Testing (POCT) for Chronic Disease by Type (2020-2031)
Figure 54. Global Point-of-care Testing (POCT) for Chronic Disease Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Point-of-care Testing (POCT) for Chronic Disease by Application (2020-2031)
Figure 56. Global Revenue Market Share of Point-of-care Testing (POCT) for Chronic Disease by Application (2020-2031)
Figure 57. Global Point-of-care Testing (POCT) for Chronic Disease Price (US$/Unit) by Application (2020-2031)
Figure 58. Point-of-care Testing (POCT) for Chronic Disease Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
